London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
What is the relevance of the incanthera paper loss to the immupharma investment case today? Answer - very little. At the time they made the incanthera investment in 2018, immuoharma had over £9m on the balance sheet. They now have sub £500k. The shares are also now at a materially lower level of valuation. So the paper loss is already reflected in the immupharma valuation, and evidently the value of the cash from an operating perspective is more important now than it was back in 2018… This is all pretty obvious stuff - unless of course your objective is to always invent a counterpoint, and never make a decision… GLA
It is often forgotten, that immupharma rose from circa 25p up to around 180p, and many investors locked in profits and made money. From memory, nolupus was not amongst them… Personally I would rather hear from somebody with a history of making decisions and getting some wrong, than the views of someone whose apparent objective is to never make a decision at all… ATB
That may be, and I cannot answer for the individual as we have never met. But from personal observation, and investment in IMM for a while, I can vouch for a vastly greater number of high profile punters on here who were totally INCORRECT about the predicted future valuation of Imm, some of whom may have used untruths or made up numbers to justify their ramping positions.
How many Nolupus' posts has been correct or truthful?
To be here on this BB that long, this is his life. Very sad.
Nolupus has been posting correctly on this BB for longer than you have been in nappies, sonny.
Respect to him.
Nolupus is a psychotic stalker of IMM. The flashing blue lights will come to his door to put him in a straitjacket and send him back to the mental asylum.
Someone bought a few today.
market generally going off a cliff today...no one buying anything much (my trader pals tell me)
but here....we have a spark...
Bahahhaa
Frits - bet he's quaking in his boots now, waiting at the window for those flashing blue lights & ominous knock on the door.
The question that needs to be answered Nobinpus is not the financial state of IMM. It is why your continually posing on a website regards a share that you’re not invested in?
Your false and misleading information regarding IMM current fiancial status is a criminal offence and I would strongly adive you to stop as your breaking the law.
Frits
Nolupus will wait until all his ducks are in order, and buy Imm shares at 20p+… Was it 150p you paid back in 2017/18?
Dallo,
Thanks for your maths lesson..but Reality has shown us that IMM sold their stake AT 15p when the Sp was over 20p which was a large discount to the 'market price' but whatever.
Reality and fantasy , Two sides to every coin , Eyes to the stars but let's keep Our feet on the ground, please
Well if that happens I’ll be very happy 🚀
Nolupus
Small lesson in maths
Immupharma sold its holding for loss of £875,000
Warrants in unrealised profit of £1.2m at Incanthera's SP of 26.5p
If Incanthera's SP moves to say 40p then Immupharma will be well in excess of £1m profit.
Nolupus
I think the point Lord is making is that 7 months ago ,Incanthera was toast with a share price of 5p which was totally illiquid and in effect worthless with zero value on the warrants.
Regardless of Mc Carthy's mad decision to invest Immupharma's funds in it ,Incanthera could now conceivably yield Immupharma a profit of over a £1m if the Incanthera SP keeps going higher.
We have to deal in the present so this is very good news for Immupharma investors.
Now we need positive news on Immupharma related business.
Disingenuous ?
Reality IS Reality in my Book ..
Imm now need to make AT least £850k profit from the warrants just to break even on the Incanthera investment .( IS my point ) Which everyone seems to forget but whatever.....
Nolupus - I see you're being disingenuous (again) saying "paper loss of roughly £850k on the sale of the Incanthera shares".
As has previously been pointed out, given IMM's low cash position, it had to raise funds SOMEHOW if it was to exercise the 7.3m Incanthera warrants at 9.5p each which are due to expire in September.
Sure, it may not have got top dollar by selling when it did. But you could argue part/most of the subsequent rise in Incanthera's share price was directly due to the disposal of IMM's stake.
As it is, IMM has raised sufficient funds to boost its cash reserves by around 800k AND to fund the 7.3m warrants. Its resulting Incanthera share stake will be even further in the money now too.
Also, IMM doesn't have to sell the Incanthera shares exercised via this warrant any time soon if it feels they've further to rise.
Well spotted, Dallo. A useful asset that has provided liquidity already, and may do so again. Regarding the wait - bear in mind we saw a long period of silence from incanthera prior to the deal news arriving out of the blue. Also, simbec orion took around 10 months from initial award of contract prior to news flow picking up in 2015/16. Latest round of share options will keep management motivated. ATB
After a paper loss of roughly £850k on the sale of the Incanthera shares , one would Hope that Imm could make Back that loss in the future..
They’ll need to sell the 7.3m shares at a significant discount to the market price like they did last week so I’d factor that in.
It looks to me like Tim is only focused on Inca now. He shipped Immu’s shares cheap at 15p to his City mates who he’s also now letting in with the equity raise he didn’t really need to do.
Unrealised gain on Immupharma's 7.3 million 9.5p warrants now stand at c£1.2m following the rise in Incanthera's share price to 26p today.
Still no news from McCarthy on Immupharma but he has lots to do over at Incanthera !
Closer to SOME form of news, possibly.
Whether it's "the news we want to hear" is still anyone's guess.
Hope so oldbutnotwisa
U do feel we are getting closer and closer to the news we want to here.
Gla
It seems to me it should follow that when we hear from Simbec-Orion, it should be decisive and be followed by the referral to FDA if it is satisfactory. Please correct me if my statement is wrong, So we wait and the SP takes nothing for granted.
Excellent post Super 👌
Post recommended
Thank you